chr2-26424409-T-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_145038.5(DRC1):​c.495T>G​(p.Ala165Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.842 in 1,613,406 control chromosomes in the GnomAD database, including 585,512 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A165A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.76 ( 46068 hom., cov: 29)
Exomes 𝑓: 0.85 ( 539444 hom. )

Consequence

DRC1
NM_145038.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.06

Publications

17 publications found
Variant links:
Genes affected
DRC1 (HGNC:24245): (dynein regulatory complex subunit 1) This gene encodes a central component of the nexin-dynein complex (N-DRC), which regulates the assembly of ciliary dynein. Mutations in this gene can cause ciliary dyskinesia. [provided by RefSeq, Aug 2015]
DRC1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 21
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • spermatogenic failure 80
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-26424409-T-G is Benign according to our data. Variant chr2-26424409-T-G is described in ClinVar as Benign. ClinVar VariationId is 262566.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.06 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.884 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_145038.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DRC1
NM_145038.5
MANE Select
c.495T>Gp.Ala165Ala
synonymous
Exon 4 of 17NP_659475.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DRC1
ENST00000288710.7
TSL:2 MANE Select
c.495T>Gp.Ala165Ala
synonymous
Exon 4 of 17ENSP00000288710.2
DRC1
ENST00000421869.5
TSL:1
n.356+3009T>G
intron
N/AENSP00000414375.1
DRC1
ENST00000497651.1
TSL:5
n.385T>G
non_coding_transcript_exon
Exon 2 of 4

Frequencies

GnomAD3 genomes
AF:
0.760
AC:
115199
AN:
151614
Hom.:
46066
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.567
Gnomad AMI
AF:
0.906
Gnomad AMR
AF:
0.695
Gnomad ASJ
AF:
0.859
Gnomad EAS
AF:
0.309
Gnomad SAS
AF:
0.771
Gnomad FIN
AF:
0.929
Gnomad MID
AF:
0.816
Gnomad NFE
AF:
0.890
Gnomad OTH
AF:
0.781
GnomAD2 exomes
AF:
0.774
AC:
194160
AN:
250974
AF XY:
0.790
show subpopulations
Gnomad AFR exome
AF:
0.554
Gnomad AMR exome
AF:
0.600
Gnomad ASJ exome
AF:
0.858
Gnomad EAS exome
AF:
0.305
Gnomad FIN exome
AF:
0.929
Gnomad NFE exome
AF:
0.892
Gnomad OTH exome
AF:
0.826
GnomAD4 exome
AF:
0.850
AC:
1243105
AN:
1461676
Hom.:
539444
Cov.:
61
AF XY:
0.851
AC XY:
618458
AN XY:
727130
show subpopulations
African (AFR)
AF:
0.555
AC:
18586
AN:
33474
American (AMR)
AF:
0.614
AC:
27473
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.852
AC:
22257
AN:
26136
East Asian (EAS)
AF:
0.306
AC:
12160
AN:
39696
South Asian (SAS)
AF:
0.780
AC:
67294
AN:
86238
European-Finnish (FIN)
AF:
0.926
AC:
49454
AN:
53408
Middle Eastern (MID)
AF:
0.801
AC:
4520
AN:
5642
European-Non Finnish (NFE)
AF:
0.892
AC:
991707
AN:
1111986
Other (OTH)
AF:
0.822
AC:
49654
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
9310
18620
27929
37239
46549
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21148
42296
63444
84592
105740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.759
AC:
115237
AN:
151730
Hom.:
46068
Cov.:
29
AF XY:
0.757
AC XY:
56137
AN XY:
74154
show subpopulations
African (AFR)
AF:
0.567
AC:
23393
AN:
41272
American (AMR)
AF:
0.694
AC:
10574
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.859
AC:
2981
AN:
3470
East Asian (EAS)
AF:
0.310
AC:
1588
AN:
5128
South Asian (SAS)
AF:
0.769
AC:
3707
AN:
4818
European-Finnish (FIN)
AF:
0.929
AC:
9791
AN:
10536
Middle Eastern (MID)
AF:
0.813
AC:
239
AN:
294
European-Non Finnish (NFE)
AF:
0.890
AC:
60496
AN:
67972
Other (OTH)
AF:
0.782
AC:
1645
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1111
2222
3332
4443
5554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.825
Hom.:
40455
Bravo
AF:
0.727
Asia WGS
AF:
0.628
AC:
2182
AN:
3478
EpiCase
AF:
0.886
EpiControl
AF:
0.888

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 21 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.055
DANN
Benign
0.39
PhyloP100
-2.1
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7423300; hg19: chr2-26647277; COSMIC: COSV56529128; API